-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

902.O5.6 902. Health Services and Outcomes Research – Malignant Diseases: Quality of Life and Health Outcomes

Health Services and Outcomes Research – Malignant Diseases Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 12:00 PM-1:30 PM
W340, Level 3 (Orange County Convention Center)
Moderators:
Heidi D Klepin, Wake Forest University School of Medicine and Smita Bhatia, MD, MPH, University of Alabama at Birmingham

Disclosures:
No relevant conflicts of interest to declare.
12:00 PM

Areej El-Jawahri, MD1, Yi-Bin Chen, MD2, Ruta Brazauskas, PhD3*, Naya He, PhD3*, Stephanie J. Lee, MD, MPH4, Jennifer M Knight, MD5, Theresa Hahn, PhD6, Nandita Khera, MD7, Jignesh D Dalal, MD8, Carmem Bonfim, MD9*, Yoshiko Atsuta, MD, Ph.D10,11* and Wael Saber, MD, MS12

1Massachusetts General Hospital/Harvard Medical School, Boston, MA
2Massachusetts General Hospital, Boston, MA
3CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Medical College of Wisconsin, Milwakee, WI
6Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
7Department of Hematology/Oncology, Mayo Clinic Arizona and Phoenix Children's Hospital, Phoenix, AZ
8Bone Marrow Transplantation, Pediatric Hematology/Oncology, The Children's Mercy Hospitals and Clincs, Kansas City, MO
9Bone Marrow Transplantation Center, Hospital de Clinicas, Universidade Federal do Paraná, Curitiba, Brazil
10Japanese Data Center for Haematopoietic Cell Transplantation, Nagoya, Japan
11Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan
12CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

12:15 PM

Ronald S. Go, MD1, Mohammed Al-Hamadani, MD, MPH2*, Cynthia S Crowson, MS3*, Nilay D Shah, PhD4* and Elizabeth B Habermann, PhD, MPH5*

1Division of Hematology, Mayo Clinic, Rochester, MN
2Gundersen Medical Foundation, La Crosse, WI
3Department of Health Sciences Research, Mayo Clinic, Rochester, MN
44Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN
5Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN

12:30 PM

Shana Traina, PhD1*, Graeme Fraser, MD FRCPC2, Paula Cramer, MD3*, Rodrigo Santucci Silva, MD4, Sebastian Grosicki, MD, PhD5, Marie Sarah Dilhuydy, MD6*, Michelle Mahler, MD7*, Mariya Salman, PhD7* and Angela Howes, PhD8

1Janssen Pharmaceutical Research & Development, Raritan, NJ
2Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
3Department I of Internal Medicine, University of Cologne, Cologne, Germany
4Hemomed Oncologia e Hematologia, IEP São Lucas, São Paulo, Brazil
5Silesian Medical University, Katowice, Poland
6Hôpital Haut-Lévêque, Pessac, France
7Janssen Research & Development, Raritan, NJ
8Janssen Research & Development, High Wycombe, United Kingdom

12:45 PM

Roberto A. Ferro, MD1, Valerie Shostrom, MS1*, Julie M. Vose, MD1, Krishna Gundabolu, MD2, Smith Giri, MBBS3, KM Monirul Islam, MD/PhD4*, Lori J. Maness, MD2, James Olen Armitage, MD1 and Vijaya R. Bhatt, MD2

1University of Nebraska Medical Center, Omaha, NE
2Hematology-Oncology, University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE
3Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN
4University of Nebraska Medical Center, Omaha

1:00 PM

Thilo Mengling, MD1*, Camila J. Hernandez Frederick, PhD1*, Daniel Fandel, MS1*, Jürgen Sauter, PhD1*, Johannes Schetelig, MD, M.Sc2, Alexander H. Schmidt, MD, PhD1 and Gerhard Ehninger, MD3

1DKMS German Bone Marrow Donor Center, Tübingen, Germany
2DKMS German Bone Marrow Donor Center, Dresden, Germany
3Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany

1:15 PM

Stephanie J. Lee, MD, MPH1, Brent Logan, PhD2*, Peter Westervelt, MD, PhD3, Corey S Cutler, MD, MPH4, Ann E Woolfrey, MD5, Shakila Khan, MD6, Edmund K Waller, MD, PhD7, Richard T. Maziarz, MD8, Juan Wu9*, Bronwen E. Shaw, MBChB, PhD, MRCP, MRCPath10*, Dennis L. Confer, MD11, Mary M. Horowitz, MD, MS12 and Claudio Anasetti, M.D.13

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Division of biostatistics, Medical College of Wisconsin, Milwuakee, WI
3Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
4Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5Transplantation Biology Department, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Division of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN
7Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
8Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health & Science University, Portland, OR
9The Emmes Corporation, Rockville, MD
10CIBMTR, Medical College of Wisconsin, Milwaukee, WI
11National Marrow Donor Program, Minneapolis, MN
12CIBMTR (Center for International Blood & Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
13Dept. of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL

*signifies non-member of ASH